XML 22 R15.htm IDEA: XBRL DOCUMENT
v3.24.3

Stockholders' Equity | 9 Months Ended
--- | ---
Sep. 30, 2024
Equity [Abstract] |
Stockholders' Equity | NOTE 8. — STOCKHOLDERS’ EQUITY A summary of the changes in stockholders’ equity for the three and nine months ended September 30, 2024 and 2023 is as follows (in thousands except per share amounts):
|  | Common Stock |  |  | Accumulated Other Comprehensive |  |  | Additional Paid-in |  |  | Dividends Paid in Excess |  |  |  |
|  | Shares |  |  | Amount |  |  | Income |  |  | Capital |  |  | of Earnings |  |  | Total |
BALANCE, JUNE 30, 2024 |  |  | 54,185 |  |  | $ | 542 |  |  | $ | (1,051 | ) |  | $ | 1,062,204 |  |  | $ | (110,661 | ) |  | $ | 951,034 |
Net earnings |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 15,335 |  |  |  | 15,335 |
Accumulated other comprehensive income (loss) |  |  | — |  |  |  | — |  |  |  | (2,923 | ) |  |  | — |  |  |  | — |  |  |  | (2,923 | )
Dividends declared — $0.45 per share |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (25,421 | ) |  |  | (25,421 | )
Shares issued pursuant to equity offering, net |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (102 | ) |  |  | — |  |  |  | (102 | )
Shares issued pursuant to ATM Program, net |  |  | 831 |  |  |  | 8 |  |  |  | — |  |  |  | 23,883 |  |  |  | — |  |  |  | 23,891 |
Shares issued pursuant to dividend reinvestment |  |  | 1 |  |  |  | — |  |  |  | — |  |  |  | 16 |  |  |  | — |  |  |  | 16 |
Stock-based compensation and settlements |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1,561 |  |  |  | — |  |  |  | 1,561 |
BALANCE, SEPTEMBER 30, 2024 |  |  | 55,017 |  |  | $ | 550 |  |  | $ | (3,974 | ) |  | $ | 1,087,562 |  |  | $ | (120,747 | ) |  | $ | 963,391 |
BALANCE, DECEMBER 31, 2023 |  |  | 53,953 |  |  | $ | 540 |  |  |  | (4,021 | ) |  | $ | 1,053,129 |  |  | $ | (94,096 | ) |  | $ | 955,552 |
Net earnings |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 48,769 |  |  |  | 48,769 |
Accumulated other comprehensive income (loss) |  |  | — |  |  |  | — |  |  |  | 47 |  |  |  | — |  |  |  | — |  |  |  | 47 |
Dividends declared — $1.35 per share |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (75,420 | ) |  |  | (75,420 | )
Shares issued pursuant to equity offering, net |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (160 | ) |  |  | — |  |  |  | (160 | )
Shares issued pursuant to ATM Program, net |  |  | 1,049 |  |  |  | 10 |  |  |  | — |  |  |  | 31,086 |  |  |  | — |  |  |  | 31,096 |
Shares issued pursuant to dividend reinvestment |  |  | 1 |  |  |  | — |  |  |  | — |  |  |  | 46 |  |  |  | — |  |  |  | 46 |
Stock-based compensation and settlements |  |  | 14 |  |  |  | — |  |  |  | — |  |  |  | 3,461 |  |  |  | — |  |  |  | 3,461 |
BALANCE, SEPTEMBER 30, 2024 |  |  | 55,017 |  |  | $ | 550 |  |  | $ | (3,974 | ) |  | $ | 1,087,562 |  |  | $ | (120,747 | ) |  | $ | 963,391 |
|  | Common Stock |  |  | Accumulated Other Comprehensive |  |  | Additional Paid-in |  |  | Dividends Paid in Excess |  |  |  |
|  | Shares |  |  | Amount |  |  | Income |  |  | Capital |  |  | of Earnings |  |  | Total |
BALANCE, JUNE 30, 2023 |  |  | 50,501 |  |  | $ | 505 |  |  | $ | — |  |  | $ | 938,163 |  |  | $ | (78,582 | ) |  | $ | 860,086 |
Net earnings |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 16,033 |  |  |  | 16,033 |
Dividends declared — $0.43 per share |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (23,209 | ) |  |  | (23,209 | )
Shares issued pursuant to equity offering, net |  |  | 2,200 |  |  |  | 22 |  |  |  | — |  |  |  | 71,564 |  |  |  | — |  |  |  | 71,586 |
Shares issued pursuant to ATM Program, net |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (45 | ) |  |  | — |  |  |  | (45 | )
Shares issued pursuant to dividend reinvestment |  |  | 1 |  |  |  | — |  |  |  | — |  |  |  | 12 |  |  |  | — |  |  |  | 12 |
Stock-based compensation and settlements |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1,443 |  |  |  | — |  |  |  | 1,443 |
BALANCE, SEPTEMBER 30, 2023 |  |  | 52,702 |  |  | $ | 527 |  |  | $ | — |  |  | $ | 1,011,137 |  |  | $ | (85,758 | ) |  | $ | 925,906 |
|  |  |  |  |  |  |  | $ | — |  |  |  |  |  |  |  |  |  |
BALANCE, DECEMBER 31, 2022 |  |  | 46,735 |  |  | $ | 467 |  |  |  | — |  |  | $ | 822,340 |  |  | $ | (62,957 | ) |  | $ | 759,850 |
Net earnings |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 43,639 |  |  |  | 43,639 |
Dividends declared — $1.29 per share |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (66,440 | ) |  |  | (66,440 | )
Shares issued pursuant to equity offering, net |  |  | 2,200 |  |  |  | 22 |  |  |  | — |  |  |  | 71,509 |  |  |  | — |  |  |  | 71,531 |
Shares issued pursuant to ATM Program, net |  |  | 3,721 |  |  |  | 38 |  |  |  | — |  |  |  | 114,089 |  |  |  | — |  |  |  | 114,127 |
Shares issued pursuant to dividend reinvestment |  |  | 1 |  |  |  | — |  |  |  | — |  |  |  | 40 |  |  |  | — |  |  |  | 40 |
Stock-based compensation and settlements |  |  | 45 |  |  |  | — |  |  |  | — |  |  |  | 3,159 |  |  |  | — |  |  |  | 3,159 |
BALANCE, SEPTEMBER 30, 2023 |  |  | 52,702 |  |  | $ | 527 |  |  | $ | — |  |  | $ | 1,011,137 |  |  | $ | (85,758 | ) |  | $ | 925,906 |
On March 1, 2024, our Board of Directors granted 271,250 restricted stock units (“RSU” or “RSUs”), under our Amended and Restated 2004 Omnibus Incentive Compensation Plan. On March 1, 2023, our Board of Directors granted 253,075 RSUs under our Amended and Restated 2004 Omnibus Incentive Compensation Plan. Common Stock Offerings In July 2024, we completed a follow-on public offering of 4.0 million shares of common stock in connection with forward sales agreements (the "July 2024 Forward Offering"). Upon settlement, the July 2024 Forward Offering is anticipated to raise total gross proceeds of approximately $121.1 million. No shares were settled during the three and nine months ended September 30, 2024 and we expect to settle the forward sale agreements in full within 12 months via physical delivery of the outstanding shares of common stock in exchange for cash proceeds. In February 2023, we completed a follow-on public offering the "February 2023 Forward Offering") of 3.5 million shares of common stock in connection with forward sales agreements. During the three months ended September 30, 2023, we settled 2.2 million shares of common stock from the February 2023 Forward Offering, realizing net proceeds of $71.5 million. During the year ended December 31, 2023, we settled all 3.5 million shares and realized net proceeds of $112.1 million. ATM Program In February 2023, we established and, in February 2024, we amended, an at-the-market equity offering program (the “ATM Program”), pursuant to which we are able to issue and sell shares of our common stock with an aggregate sales price of up to $350.0 million through a consortium of banks acting as our sales agents or acting as forward sellers on behalf of any forward purchasers pursuant to a forward sale agreement. Sales of the shares of common stock may be made, as needed, from time to time in at-the-market offerings as defined in Rule 415 of the Securities Act, including by means of ordinary brokers’ transactions on the New York Stock Exchange or otherwise at market prices prevailing at the time of sale, at prices related to prevailing market prices or as otherwise agreed to with the applicable agent. The use of a forward sale agreement allows us to lock in a share price on the sale of shares at the time the forward sales agreement becomes effective, but defer receiving the proceeds from the sale of shares until a later date. To account for the forward sale agreements, we consider the accounting guidance governing financial instruments and derivatives. To date, we have concluded that our forward sale agreements are not liabilities as they do not embody obligations to repurchase our shares nor do they embody obligations to issue a variable number of shares for which the monetary value are predominantly fixed, varying with something other than the fair value of the shares, or varying inversely in relation to our shares. We also evaluated whether the agreements meet the derivatives and hedging guidance scope exception to be accounted for as equity instruments. We concluded that the agreements are classifiable as equity contracts based on the following assessments: (i) none of the agreements’ exercise contingencies are based on observable markets or indices besides those related to the market for our own stock price and operations, and (ii) none of the settlement provisions precluded the agreements from being indexed to its own stock. We also consider the potential dilution resulting from the forward sale agreements on the earnings per share calculations. We use the treasury stock method to determine the dilution resulting from the forward sale agreements during the period of time prior to settlement. ATM Direct Issuances During the three and nine months ended September 30, 2024 and 2023, no shares of common stock were issued under the ATM Program. Future sales, if any, will depend on a variety of factors to be determined by us from time to time, including among others, market conditions, the trading price of our common stock, determinations by us of the appropriate sources of funding for us and potential uses of funding available to us. ATM Forward Sale Agreements During the three months ended September 30, 2024 and 2023, we did not enter into any forward sale agreements under the ATM Program. During the nine months ended September 30, 2024, we entered into forward sale agreements to sell an aggregate of 0.4 million shares of common stock at an average gross offering price of $27.98 per share and, during the nine months ended September 30, 2023, we entered into forward sale agreements to sell an aggregate of 0.2 million shares of common stock at an average gross offering price of $34.97 per share. During the three and nine months ended September 30, 2024, we settled 0.8 million shares and 1.0 million shares, respectively, of common stock subject to forward sale agreements under the ATM Program for net proceeds of $23.9 million and $31.1 million, respectively, after deducting fees and expenses and making certain other adjustments as provided in the equity distribution agreement. During the nine months ended September 30, 2023, we settled 3.7 million shares of common stock subject to forward sale agreements under the ATM Program for net proceeds of $114.1 million, after deducting fees and expenses and making certain other adjustments as provided in the equity distribution agreement. As September 30, 2024, we had 0.4 million shares of common stock outstanding subject to forward sale agreements under the ATM Program. We expect to settle the forward sale agreements in full within 12 months of the respective agreement dates via physical delivery of the outstanding shares of common stock in exchange for cash proceeds, although we may elect cash settlement or net share settlement for all or a portion of our obligations under the forward sale agreements, subject to certain conditions. Dividends For the nine months ended September 30, 2024, we paid regular quarterly dividends of $74.8 million or $1.35 per share. For the nine months ended September 30, 2023, we paid regular quarterly dividends of $63.8 million or $1.29 per share. Dividend Reinvestment Plan Our dividend reinvestment plan provides our common stockholders with a convenient and economical method of acquiring additional shares of common stock by reinvesting all or a portion of their dividend distributions. During the nine months ended September 30, 2024 and 2023, we issued 1,643 and 1,178 shares of common stock, respectively, under the dividend reinvestment plan and received proceeds of approximately $46 thousand and $40 thousand, respectively. Stock-Based Compensation Stock-based compensation expense using the fair value method was $4.5 million and $4.2 million for the nine months ended September 30, 2024 and 2023, respectively, and is included in general and administrative expense on our consolidated statements of operations.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for equity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 16 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration